Hydrochloride is the active ingredient in medications containing mefloquine.
Prevention of malaria in areas where chloroquineresistant malaria is prevalent.
Treatment of uncomplicated malaria in areas where chloroquineresistant malaria is prevalent.
Larium 250mg Tab (Mefloquine) is an antimalarial drug that works by preventing the parasite Plasmodium falciparum from multiplying within red blood cells. It inhibits the parasite's growth by interfering with its DNA replication and protein synthesis.
Store mefloquine tablets at room temperature, away from moisture and light. Keep out of reach of children.
The dosage of mefloquine varies depending on the individual's age, weight, and the reason for taking the medication. It is crucial to follow your doctor's instructions carefully.
Mefloquine tablets are typically taken once a week, usually on the same day each week.
For malaria prevention, the medication is usually started 1-2 weeks before travelling to a malaria-prone area and continued for 4 weeks after leaving the area.
For treatment of malaria, mefloquine is typically taken for 3 days.
Neurological problems, such as seizures and peripheral neuropathy
Nausea and vomiting
Diarrhea
Abdominal pain
Dizziness
Headache
Sleep disturbances
Mood changes, including depression, anxiety, and psychosis
Skin rash
Alcohol consumption may increase the risk of side effects. Consult your doctor regarding alcohol consumption while taking mefloquine.
Mefloquine can cause dizziness and drowsiness. Avoid driving or operating machinery until you know how this medication affects you.
Mefloquine can harm an unborn baby. It is not recommended for pregnant women. Consult your doctor before taking this medication if you are breastfeeding.
Mefloquine is not recommended for children under the age of 5.
Mefloquine is excreted through the kidneys. Individuals with kidney problems may require dose adjustments. Consult your doctor if you have kidney problems.
Mefloquine can cause liver problems. If you experience symptoms like jaundice, dark urine, or light-colored stools, contact your doctor immediately.
The United States Pharmacopeia (USP)
The National Institutes of Health (NIH)
The Centers for Disease Control and Prevention (CDC)
The World Health Organization (WHO)
